Today, we had our first larger workshop of our flagship project PRECIOUS, a Design and Trial Service for Patient-Reported Outcomes and Precision Digital Therapeutics (PDTx) developed in close collaboration with our implementation partner Pathmate Technologies.

Hosted in Zurich, this first workshop brought together researchers and developers. Together, we developed a first shared vision and explored the specific innovation modules on the prediction and prevention of non-adherence, GenAI-supported precision intervention, and the integration of agentic AI and other intervention components such as Breeze as plugins. We also began co-designing the next phases of co-development.

The participants included Dr. Marcia Nißen, Alexandre de Montleau, Felix Moser, Helen Galliker, Marinja Principe, Qiuhan Jin, Dr. Rasita Vinay, Sophie Krenböck, Tobias Budig, Izia Xiao, Dr. Jacqueline Mair, Akshaye Shenoi, Sabra Melamed, and Tobias Kowatsch – the research team – and Dr. Dirk Volland,  Andreas Filler, Dr. Claire-Michelle Sevin, Dr. Dominik Rüegger, Susanne Müller and Frédéric Mullis from Pathmate Technologies.

This marks a promising first step toward building a modular, AI-powered infrastructure to support personalized, scalable, and regulatory-compliant precision digital therapeutics.

More to come as we continue shaping the future of digital health! Stay tuned!